Business Context and Reporting Period
Company: Semtech Corporation
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Third quarter and nine months ended October 30, 2005
Business Overview: Semtech designs, produces, and markets semiconductor products for computer, communications, and industrial markets. The company operates two segments: Standard Semiconductor Products (power management, protection, test/measurement, communications, and wireless/sensing) and Rectifier, Assembly and Other Products. On June 23, 2005, Semtech acquired XEMICS SA to expand its wireless and sensing capabilities.
Key Financial Metrics
| Metric (in thousands) | Q3 2005 | Q3 2004 | 9M 2005 | 9M 2004 |
|---|---|---|---|---|
| Net Sales | $60,870 | $64,987 | $175,033 | $195,185 |
| Gross Profit | $34,265 | $37,220 | $98,059 | $114,837 |
| Gross Margin | 56.3% | 57.3% | 56.0% | 58.8% |
| Operating Income | $11,710 | $16,956 | $33,117 | $56,567 |
| Net Income | $11,518 | $14,595 | $29,726 | $46,779 |
| Diluted EPS | $0.15 | $0.19 | $0.39 | $0.60 |
| Cash & Equivalents | $57,808 | $79,362 (End Q3 2004) | Balance Sheet Oct 30, 2005: $57,808 | |
| Total Investments | Temporary ($109.5M) + Long-term ($100.5M) = $210.0M | |||
| Working Capital | $205.4 million (Oct 30, 2005) | |||
| Long-Term Debt | None |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6% in Q3 and 10% for the nine-month period compared to the prior year. This was driven by significant declines in Automated Test Equipment (ATE) applications (-53% Q3, -73% 9M), cellular phone products (-31% Q3, -24% 9M), and notebook computers (-25% Q3, -19% 9M). These were partially offset by growth in desktop computers and industrial applications.
- Margin Compression: Gross margin declined to 56.3% in Q3 (from 57.3%) and 56.0% for the nine months (from 58.8%). This was attributed to lower average selling prices, lower manufacturing overhead utilization, and a shift in product mix away from high-margin ATE products.
- Operating Expenses: Operating expenses increased 11% in Q3 and 11% for the nine months. Increases were driven by higher Product Development and Engineering costs (15% increase in Q3) and acquisition-related costs ($409k in Q3, $4.5M in 9M) associated with the XEMICS acquisition.
- Insurance Settlements: The company recorded a net gain of $630k for the nine months ended Oct 30, 2005, related to settlements with two insurance companies regarding a past customer dispute, partially offset by legal expenses. In Q3 specifically, legal expenses ($502k) exceeded settlements, resulting in a net charge.
- Acquisition Impact: The acquisition of XEMICS contributed $6.5 million in sales in Q3. One-time charges included a $4.0 million write-off of in-process R&D in Q2 and amortization of intangibles in Q3.
Guidance, Outlook, Risks, and Unusual Items
- Outlook: Management expects to continue investing in new product development and engineering. The company believes operating cash flows and cash reserves are sufficient to fund operations and any potential earn-out payments for the XEMICS acquisition.
- Unusual Items:
- XEMICS Acquisition: Total transaction value approx. $59.0 million. Includes a contingent earn-out of up to $16.0 million payable if performance objectives are met by April 30, 2006.
- Insurance Litigation: A case against the third insurance company regarding the customer dispute is expected to go to trial in Q1 fiscal 2007. Future legal expenses may exceed recoveries.
- Tax Provision: A favorable foreign tax exclusion reduced the current period tax provision by approximately $1.8 million.
- Risks:
- Supply Chain: Heavy reliance on foreign subcontractors (China, Malaysia, Philippines) for wafer fabrication and assembly. Disruptions could materially impact shipments.
- Customer Concentration: One cellular phone manufacturer accounted for ~12% of Q3 sales. Two Asian distributors accounted for ~12% and ~11% of Q3 sales.
- Market Cyclicality: Significant exposure to cyclical end-markets (computers, communications) which are sensitive to economic downturns.
- Accounting Changes: The company plans to adopt SFAS No. 123(R) regarding share-based payment in Q1 fiscal 2007, which will require expensing stock options and likely reduce reported earnings.
Investor Verification Checklist
- XEMICS Integration: Verify the progress of integrating XEMICS' wireless and sensing technologies and the likelihood of meeting the $16 million earn-out targets.
- Insurance Litigation Outcome: Monitor the status of the pending trial against the third insurance company and potential legal cost exposure.
- End-Market Recovery: Assess the trajectory of demand in ATE, cellular, and notebook markets, which drove the recent revenue decline.
- Stock-Based Compensation Impact: Review the projected impact of adopting SFAS 123(R) in fiscal 2007 on future earnings per share.
- Supply Chain Resilience: Evaluate the company's contingency plans for its reliance on foreign foundries and assembly houses, particularly in China and Southeast Asia.